239 related articles for article (PubMed ID: 22173427)
21. Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial.
Paikin JS; Haroun MJ; Eikelboom JW
Expert Rev Cardiovasc Ther; 2011 Mar; 9(3):279-86. PubMed ID: 21438804
[TBL] [Abstract][Full Text] [Related]
22. The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).
Reilly PA; Lehr T; Haertter S; Connolly SJ; Yusuf S; Eikelboom JW; Ezekowitz MD; Nehmiz G; Wang S; Wallentin L;
J Am Coll Cardiol; 2014 Feb; 63(4):321-8. PubMed ID: 24076487
[TBL] [Abstract][Full Text] [Related]
23. Thromboembolic prophylaxis in orthopedic surgery using dabigatran: an oral direct thrombin inhibitor.
Garza R; Huo MH
Expert Rev Cardiovasc Ther; 2012 Apr; 10(4):423-7. PubMed ID: 22458575
[TBL] [Abstract][Full Text] [Related]
24. [Direct oral thrombin inhibitor, "dabigatran"].
Yasaka M
Nihon Rinsho; 2013 Jan; 71(1):113-8. PubMed ID: 23631181
[TBL] [Abstract][Full Text] [Related]
25. New anticoagulant drugs among elderly patients is caution necessary?: Comment on "The use of dabigatran in elderly patients".
Jacobs JM; Stessman J
Arch Intern Med; 2011 Jul; 171(14):1287-8. PubMed ID: 21788546
[No Abstract] [Full Text] [Related]
26. Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses.
Pink J; Lane S; Pirmohamed M; Hughes DA
BMJ; 2011 Oct; 343():d6333. PubMed ID: 22042753
[TBL] [Abstract][Full Text] [Related]
27. Hemorrhagic gastritis with dabigatran in a patient with renal insufficiency.
Fellows SE; Rosini JM; Curtis JA; Volz EG
J Emerg Med; 2013 Feb; 44(2):e221-5. PubMed ID: 22595629
[TBL] [Abstract][Full Text] [Related]
28. Dabigatran etexilate, a new oral direct thrombin inhibitor, for stroke prevention in patients with atrial fibrillation.
Siddiqui FM; Qureshi AI
Expert Opin Pharmacother; 2010 Jun; 11(8):1403-11. PubMed ID: 20446854
[TBL] [Abstract][Full Text] [Related]
29. [Direct inhibitors of thrombin, hirudin, bivalirudin, and dabigatran etexilate].
Meddahi S; Samama MM
J Mal Vasc; 2011 Feb; 36(1):24-32. PubMed ID: 21239127
[TBL] [Abstract][Full Text] [Related]
30. Spontaneous splenic hemorrhage after initiation of dabigatran (Pradaxa) for atrial fibrillation.
Moore CH; Snashall J; Boniface K; Scott J
Am J Emerg Med; 2012 Nov; 30(9):2082.e1-2. PubMed ID: 22196949
[TBL] [Abstract][Full Text] [Related]
31. Dabigatran: will it change clinical practice?
Wartak SA; Bartholomew JR
Cleve Clin J Med; 2011 Oct; 78(10):657-64. PubMed ID: 21968472
[TBL] [Abstract][Full Text] [Related]
32. Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.
Baetz BE; Spinler SA
Pharmacotherapy; 2008 Nov; 28(11):1354-73. PubMed ID: 18956996
[TBL] [Abstract][Full Text] [Related]
33. Dabigatran etexilate (Pradaxa) for the treatment of atrial fibrillation.
Belavic JM
Nurse Pract; 2011 Sep; 36(9):6-7. PubMed ID: 21857210
[No Abstract] [Full Text] [Related]
34. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
35. Dabigatran for stroke prevention in atrial fibrillation.
Hohnloser SH; Diener HC
Hamostaseologie; 2012; 32(3):216-20. PubMed ID: 22739760
[TBL] [Abstract][Full Text] [Related]
36. Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.
Berger R; Salhanick SD; Chase M; Ganetsky M
Ann Emerg Med; 2013 Apr; 61(4):475-9. PubMed ID: 23522810
[TBL] [Abstract][Full Text] [Related]
37. Potential inaccuracy of point-of-care INR in dabigatran-treated patients.
Baruch L; Sherman O
Ann Pharmacother; 2011 Jul; 45(7-8):e40. PubMed ID: 21712509
[TBL] [Abstract][Full Text] [Related]
38. Impaired renal function and bleeding in elderly treated with dabigatran.
Berthelot E; Lavenu-Bombled C; Orostegui-Giron L; Desconclois C; Assayag P
Blood Coagul Fibrinolysis; 2014 Sep; 25(6):618-20. PubMed ID: 24509332
[TBL] [Abstract][Full Text] [Related]
39. Dabigatran: a cause of hematologic emergency.
Lal Y; Van Heukelom J
Am J Med Sci; 2013 Sep; 346(3):190-3. PubMed ID: 23221509
[TBL] [Abstract][Full Text] [Related]
40. Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.
Uchiyama S; Ibayashi S; Matsumoto M; Nagao T; Nagata K; Nakagawara J; Tanahashi N; Tanaka K; Toyoda K; Yasaka M
J Stroke Cerebrovasc Dis; 2012 Apr; 21(3):165-73. PubMed ID: 22440950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
